Patents by Inventor Marcel Menard

Marcel Menard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7246825
    Abstract: An erosion-indicating safety fitting having a fluid passage formed within for connection in-line with a pipe and a cage of interconnecting breach passages formed into the block and surrounding the fluid passage, particularly at areas having a predicted risk of erosion. A pressure gauge, connected to the breach passages, registers a change in pressure to equal that of the pressure in the fluid passage should the material between the fluid passage and one or more of the breach passages be eroded by the flow of particulate-laden fluid within the fluid passage. The fitting can then be changed before compromising the safety of personnel and the environment.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: July 24, 2007
    Assignee: Worldwide Matrix Inc.
    Inventor: Marcel Menard
  • Publication number: 20050082822
    Abstract: An erosion-indicating safety fitting having a fluid passage formed within for connection in-line with a pipe and a cage of interconnecting breach passages formed into the block and surrounding the fluid passage, particularly at areas having a predicted risk of erosion. A pressure gauge, connected to the breach passages, registers a change in pressure to equal that of the pressure in the fluid passage should the material between the fluid passage and one or more of the breach passages has been eroded by the flow of particulate-laden fluid within the fluid passage. The fitting can then be changed before compromising the safety of personnel and the environment.
    Type: Application
    Filed: September 29, 2004
    Publication date: April 21, 2005
    Inventor: Marcel Menard
  • Patent number: 5672701
    Abstract: Compounds of the formula ##STR1## wherein A is an unsubstituted or hydroxy-substituted straight or branched C.sub.1-10 alkylene group or a straight or branched C.sub.1-10 alkylene group having an intervening heteroatom selected from oxygen, sulfur and nitrogen;R.sup.2 is hydroxy, halogen, C.sub.1-4 alkoxy, nitrile, azido, a quaternary ammonio group, --NR.sup.5 R.sup.6, ##STR2## azetidinyl, or a 5- or 6-membered heterocyclic group selected from heteroaromatic and heteroalicyclic joined through a carbon atom thereof;or a non-toxic pharmaceutically acceptable salt thereof, are novel antimicrobial agents which are useful in the treatment of infectious disease in humans and other animals. Novel intermediates and processes for their preparation are also disclosed.
    Type: Grant
    Filed: January 26, 1995
    Date of Patent: September 30, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alain Martel, Carol Bachand, Marcel Menard
  • Patent number: 4461727
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic radicals and X represents certain hetero-interrupted substituted alkyl radicals. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: September 10, 1982
    Date of Patent: July 24, 1984
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4406834
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic radicals and X represents certain hetero-interrupted substituted alkyl radicals. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: April 13, 1981
    Date of Patent: September 27, 1983
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4378314
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic substituents and X represents certain organic substituents. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: October 24, 1980
    Date of Patent: March 29, 1983
    Assignee: Bristol Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4374065
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic radicals and X represents certain hereto-interrupted substituted alkyl radicals. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: April 13, 1981
    Date of Patent: February 15, 1983
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4282150
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic radicals and X represents certain hetero-interrupted substituted alkyl radicals. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: September 21, 1979
    Date of Patent: August 4, 1981
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4272437
    Abstract: This invention relates to 2-substituted and 2,6-disubstituted penem compounds of the formula ##STR1## wherein Y is hydrogen, halo or certain organic substituents and X represents certain organic substituents. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3-position is protected as by an easily removable ester protecting group. The compounds of the present invention are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: September 21, 1979
    Date of Patent: June 9, 1981
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Alain Martel
  • Patent number: 4171439
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is halo or hydroxyl and X is acylamino. Also included in the invention are compounds of the above formula in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds. The compounds are potent antibacterial agents.
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: October 16, 1979
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4169833
    Abstract: Disclosed are novel phosphorane intermediates of the formula ##STR1## wherein Z is phenyl or C.sub.1 -C.sub.6 alkyl. The intermediates are of use in preparing 2-penem-3-carboxylic acid compounds having potent antibacterial activity.
    Type: Grant
    Filed: October 4, 1978
    Date of Patent: October 2, 1979
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gilles Caron
  • Patent number: 4166905
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is etherified hydroxyl and X is acylamino. Also included in the invention are compounds of the above formula in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds. The compounds are potent antibacterial agents.
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: September 4, 1979
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4166906
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is hydroxyl esterified with a sulfonic acid residue and X is acylamino. Also included in the invention are compounds of the above formula in which the carboxyl group of the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds. The compounds are potent antibacterial agents.
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: September 4, 1979
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4155912
    Abstract: There is described the preparation of novel 2-penem-3-carboxylic acid compounds having the formula ##STR1## and easily cleavable esters and carboxylic acid salts thereof. The compounds of formula I, particularly the dextrorotatory isomers thereof, are potent antibacterial agents or are of use as intermediates in the preparation of such agents.
    Type: Grant
    Filed: December 14, 1977
    Date of Patent: May 22, 1979
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gilles Caron
  • Patent number: 4112230
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is halo, hydroxyl, etherified hydroxyl or hydroxyl esterified with a carboxylic acid residue or a sulfonic acid residue and X is amino, azido or acylamino. Also included in the invention are compounds of formula I in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: January 17, 1977
    Date of Patent: September 5, 1978
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4068080
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1, 6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is halo, hydroxyl, etherified hydroxyl or hydroxyl esterified with a carboxylic acid residue or a sulfonic acid residue and X is amino, azido or acylamino. Also included in the invention are compounds of formula I in which the carbonyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: August 19, 1976
    Date of Patent: January 10, 1978
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4068075
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is halo, hydroxyl, etherified hydroxyl or hydroxyl esterified with a carboxylic acid residue or a sulfonic acid residue and X is amino, azido or acylamino. Also included in the invention are compounds of formula I in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: August 19, 1976
    Date of Patent: January 10, 1978
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4068078
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is halo, hydroxyl, etherified hydroxyl or hydroxyl esterified with a carboxylic acid residue or a sulfonic acid residue and X is amino, azido or acylamino. Also included in the invention are compounds of formula I in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: August 19, 1976
    Date of Patent: January 10, 1978
    Assignee: Bristol-Myers Corporation
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4066832
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1##wherein Z is halo, hydroxyl, etherified hydroxyl or hydroxyl esterified with a carboxylic acid residue or a sulfonic acid residue and X is amino, azido or acylamino. Also included in the invention are compounds of formula I in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: August 19, 1976
    Date of Patent: January 3, 1978
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway
  • Patent number: 4011216
    Abstract: There is described the stereoselective total synthesis of novel .DELTA..sup.2,3 -1,4-morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1, 6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula ##STR1## wherein Z is hydroxyl esterified with a carboxylic acid residue and X is amino. Also included in the invention are compounds of formula I in which the carboxyl group at the 2-position is protected as by an easily cleavable ester group and salts of both the free acids and carboxyl-protected compounds of formula I. The compounds of formula I are potent antibacterial agents or are of use as intermediates in the preparation of such antibacterial agents.
    Type: Grant
    Filed: April 11, 1975
    Date of Patent: March 8, 1977
    Assignee: Bristol-Myers Company
    Inventors: Marcel Menard, Gary M. F. Lim, Terry T. Conway